Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Efficacy of concurrent chemoradiotherapy for patients with limited-disease small-cell lung cancer: a retrospective, nationwide, population-based cohort study

Fig. 3

a Kaplan–Meier curves for overall survival (OS) in patients with limited-disease (LD) small-cell lung cancer (SCLC) who received combination chemotherapy or monotherapy (mono) as second-line treatment. b Kaplan–Meier curve for OS in patients with LD-SCLC who received the irinotecan/platinum (IP) or etoposide/platinum (EP) combination as second-line treatment. EP, etoposide/platinum; IP, irinotecan/platinum; CI, confidence interval

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us